A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses
This study has been completed.
Sponsor:
Actavis Mid-Atlantic LLC
Information provided by (Responsible Party):
Actavis Mid-Atlantic LLC
ClinicalTrials.gov Identifier:
NCT01502020
First received: December 23, 2011
Last updated: December 29, 2011
Last verified: December 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2011 |
| Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |